CCR6 and COVID-19: Prior studies have also described a dominant CCR6 phenotype of CoV‐2 S‐specific Tmem among convalescent COVID‐19 subjects,33 and here, we find that CoV‐2 cross‐reactive responses are similarly highly CCR6‐biased (Figure 2d and e).